metastatic cancers, anti-cancer drugs (chemotherapy, hormone and biological therapies) are the choice currently used in metastasic cancers. The indiscriminate destruction of normal cells, the toxicity of conventional…
differentiation between cancerous and normal cells via nanoparticles. Another therapy method to recognize cancer cells is immunotherapy based on a targeted reaction between the antibody and the target antigen ... weak…
telomere maintenance and replicative immortality in cancer cells is telomere elongation by telomerase, and many emerging potential telomere-based therapies have focused on targeting telomerase components. By contrast…
Cancer is a disease in which normal physiological processes are imbalanced, leading to tumour formation, metastasis and eventually death. Recent biological advances have led to the advent of targeted therapies…
locally high in normal cells). In cancer cannibalism of normal cells, the growing cancer mass is a factor for progression and invasion. Cancer cells have been shown to kill normal ... immune tolerance mediating factors…
next studies examined the effects of the PAFR and miR-149-5p on targeted therapy (i.e., erlotinib and gefitinib) responses. We found that both these therapies inhibit the survival ... Travers JB, Sahu RP…
develop eff ective and safe therapies against triple negative breast cancer due to poor prognosis and lack of targeted therapies. Recently, we found that EF2-Kinase (EF2K) is signifi cantly ... that EF2-Kinase plays an…
Background: Combining three targeted therapies significantly improved outcomes in AIDS. A similar strategy could theoretically benefit patients with metastatic NSCLC, but a scientific method for rational selection of…
challenge for people working on cancer therapy. Nowadays, Nanotechnology has expressed its ability to solve these complicated and challenged issues. For such HCCs, targeted nano carriers are optimized. In this ... This…
emerged as a promising strategy to overcome the limitations of conventional cancer therapies, including poor solubility, off-target toxicity, and rapid drug clearance. By integrating multiple materials such as polymers…
Targeted therapies are transforming endometrial cancer treatment by addressing specific molecular alterations. This includes inhibitors targeting PI3K/AKT/mTOR, HER2, and DNA damage repair pathways, showing promise for…